NC Bio Pharma Networking Group April 2024 Event

Duke University spinout Tune Therapeutics is rehearsing the overture of its avant-garde therapeutic platform targeting chronic Hepatitis B Virus (HBV) that could also upend many more chronic disease treatments.

Tune, which is jointly based in Durham and Seattle, is one of a small group of gene therapy companies developing a new technology known as epigenetic editing.

The North Carolina Biotechnology Center has helped hundreds of companies achieve amazing milestones over four decades. It’s only fitting that the state’s thriving life sciences sector stop and recognize NCBiotech’s own milestone on the 40th anniversary of its founding.

Join the NC Bio Pharma Networking Group on April 30 for an inclusive evening of networking with life sciences professionals.